Fredun Pharmaceuticals

quarterly
yearly
ParticularsDec '22Mar '23Jun '23Sep '23Dec '23
Revenue77.9679.8162.0581.9887.00
Expenses73.3371.7957.9676.2281.25
EBITDA7.3112.267.619.6110.52
EBIT6.5711.566.698.679.53
Profit Before Tax4.628.014.085.775.76
Net Profit3.463.892.403.944.22
Financial Ratios
Operating Profit Margin9.41%15.38%12.43%11.79%12.14%
Net Profit Margin4.46%4.88%3.92%4.84%4.87%
Earning Per Share (Diluted)7.668.595.248.408.99
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.8.7
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ